499770-92-2 Usage
Uses
Used in Pharmaceutical Industry:
1,3-Benzothiazol-6-ylmethylamine, 97% is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic properties. Its unique chemical structure allows for the creation of molecules with specific biological activities, enhancing the effectiveness of medications.
Used in Agrochemical Industry:
In the agrochemical sector, 1,3-Benzothiazol-6-ylmethylamine, 97% serves as a crucial component in the production of pesticides and other crop protection agents. Its incorporation into these products can lead to the development of more effective and targeted agrochemicals, contributing to improved crop yields and protection against pests.
Used in Organic Chemistry Research:
As a common reagent in organic chemistry, 1,3-Benzothiazol-6-ylmethylamine, 97% is utilized in a wide range of chemical reactions for its ability to facilitate the formation of desired products. Researchers rely on its reactivity to explore new synthetic pathways and develop innovative methodologies in organic synthesis.
Used in Chemical Reactions:
1,3-Benzothiazol-6-ylmethylamine, 97% is employed in various chemical reactions, such as condensation, substitution, and rearrangement processes, due to its reactive amine group and the stability of the benzothiazol ring system. This versatility makes it a valuable tool for chemists working on the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 499770-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,9,7,7 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 499770-92:
(8*4)+(7*9)+(6*9)+(5*7)+(4*7)+(3*0)+(2*9)+(1*2)=232
232 % 10 = 2
So 499770-92-2 is a valid CAS Registry Number.
499770-92-2Relevant articles and documents
NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC
-
Paragraph 0532, (2015/03/04)
The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.
NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES
-
Paragraph 252, (2013/10/21)
The present invention provides compounds useful as C-met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of C-met kinase mediated diseases or disorders with them.
CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
-
Page/Page column 25, (2012/10/08)
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
-
Page/Page column 40, (2011/07/30)
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
NOVEL JNK INHIBITORS
-
Page/Page column 98, (2008/12/07)
Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0.
C:Corrosive;
